Peter Hecht
Fortuna: 3 M $ al 31/05/2026
Fortuna: 3 M $ al 31/05/2026
Peter M.
Hecht was the founder of Ironwood Pharmaceuticals, Inc., founded in 1998, where he served as Chief Executive Officer & Director from 1998 to 2019.
Dr. Hecht is the founder of Cyclerion Therapeutics, Inc., founded in 2019, where he serves as Director since 2023.
Dr. Hecht is currently Chief Executive Officer & Director at Tisento Therapeutics, Inc. since 2023.
Dr. Hecht is currently Director at Kallyope, Inc. since 2020.
Dr. Hecht is currently Director at Mythic Therapeutics, Inc. Dr. Hecht was Director at Microbia, Inc. Dr. Hecht was Director at Whitehead Institute for Biomedical Research.
Dr. Hecht completed undergraduate and graduate degrees at Stanford University.
Dr. Hecht earned a doctorate from the University of California, Berkeley.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CYCLERION THERAPEUTICS,INC. 12,91 % | 30/03/2026 | 559.203 ( 12,91 % ) | 2 M $ | 31/05/2026 |
| 30/03/2026 | 351.037 ( 100 % ) | 1 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CYCLERION THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/04/2019 |
Kallyope, Inc.
Kallyope, Inc. BiotechnologyHealth Technology Engages in discovering and developing of novel, neurological and metabolic therapeutics | Director/Miembro de la Junta | 20/02/2020 |
Mythic Therapeutics, Inc.
Mythic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops cancer therapeutics | Director/Miembro de la Junta | - |
Tisento Therapeutics, Inc.
Tisento Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for treat diseases | Director Ejecutivo | 01/07/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Fundador | 01/04/2019 |
Whitehead Institute for Biomedical Research
Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Provides research and technology services | Director/Miembro de la Junta | - |
Microbia, Inc.
Microbia, Inc. Pharmaceuticals: MajorHealth Technology Develops microbial manufacturing technologies | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 9 |
|---|---|
Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
Microbia, Inc.
Microbia, Inc. Pharmaceuticals: MajorHealth Technology Develops microbial manufacturing technologies | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Whitehead Institute for Biomedical Research
Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Provides research and technology services | Commercial Services |
Kallyope, Inc.
Kallyope, Inc. BiotechnologyHealth Technology Engages in discovering and developing of novel, neurological and metabolic therapeutics | Health Technology |
Cyclerion Therapeutics, Inc.
Cyclerion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products for serious and orphan diseases | Health Technology |
Mythic Therapeutics, Inc.
Mythic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops cancer therapeutics | Health Technology |
Tisento Therapeutics, Inc.
Tisento Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for treat diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.